2013 American Heart Association CVI Affiliated Participants: Talks, Moderators, Discussant, Oral Presentations, Posters, etc.
Frederick Dewey, Stanford, CA, 20356 - Moderator , Abstract Oral Session, AOS.303.01. Multiscale Omics Reveals New Mechanisms of Cardiovascular Disease, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
William Fearon, Stanford, CA, Moderator , Ask the Experts, ATE.605. PCI Guided by OCT, IVUS and FFR: What You Need to Know, Mon, Nov 18, 9:00 - 10:15 a.m.
Joshua Knowles, Stanford, CA, Moderator , Cardiovascular Seminar, CVS.312. Familial Hypercholesterolemia: Challenges and Opportunities, Tue, Nov 19, 5:30 - 6:45 p.m.
Joshua Knowles, Stanford, CA, Moderator, Familial Hypercholesterolemia: Challenges and Opportunities scheduled to start Nov 19 2013 5:30p.m.
Francois Haddad, Palo Alto, CA, Moderator , Abstract Oral Session, AOS.400.01Y. Cournand and Comroe Young Investigator Prize Finalists, Sun, Nov 17, 3:45 - 5:00 p.m.
Robert Harrington, Stanford, CA, Moderator , Early Career, EC.03. Opening General Session (Part 2) - New Paradigms and Opportunities in Cardiovascular Research for Clinical and Basic Science Researchers, Sat, Nov 16, 10:00 - 11:45 a.m.
Paul Heidenreich, Palo Alto, CA, Moderator , Early Career, EC.15. Starting a Successful Career in Quality of Care and Outcomes Research (Planned by the Council on Quality of Care and Outcomes Research), Sat, Nov 16, 3:00 - 5:00 p.m.
Daniel Murphy, Palo Alto, CA, 20862 - Moderator , Abstract Oral Session, AOS.309.01. Adult Congenital Heart Disease: Morbidity and Mortality with and Without Intervention, Mon, Nov 18, 9:00 a.m. - 12:10 p.m.
Vinicio De Jesus Perez, Stanford, CA, 20103 - Moderator , Abstract Oral Session, AOS.723.01. Novel Signaling Pathways of Pulmonary Hypertension, Tue, Nov 19, 2:00 - 5:10 p.m.
Mintu Turakhia, Palo Alto, CA, Moderator , Early Career, EC.03. Opening General Session (Part 2) - New Paradigms and Opportunities in Cardiovascular Research for Clinical and Basic Science Researchers, Sat, Nov 16, 10:00 - 11:45 a.m.
Mintu Turakhia, Palo Alto, CA, Moderator , Early Career, EC.08. Cardiac Electrophysiology Sessions for AHA Early Career Day - Part 1: Considering Electrophysiology as a Specialty, Sat, Nov 16, 1:00 - 1:45 p.m.
Mintu Turakhia, Palo Alto, CA, Moderator , Early Career, EC.14. Cardiac Electrophysiology Sessions for AHA Early Career Day--Part 2: My Story--A Panel Discussion on the Different Types of EP Career Options, Sat, Nov 16, 1:45 - 3:00 p.m.
Joseph Wu. Imaging potential novel therapies for cardiovascular diseases. Tue 11/19/2013
Joseph Wu. Novel cell, tissue engineering and gene-based strategies for heart failure. Tue 11/19/2013
Sean Wu. Developmental and reactive cardiomyocyte growth signaling. Tue 11/19/13
Daniel Bernstein, Palo Alto, CA, Specific Molecular Pathways and Targeted Therapy of Right-Heart Failure , Sunday Morning Program, SMP.504. The Lost Souls of Heart Failure: Heart Failure with Preserved Ejection Fraction and Right-Heart Failure, Sun, Nov 17, 8:00 - 11:00 a.m.
Colleen Caleshu, Stanford, CA - Ethical and Social Implications of Genetic Testing, Cardiovascular Seminar, CVS.303. Genetics in Your Practice, Sun, Nov 17, 5:30 - 6:45 PM
Colleen Caleshu, Stanford, CA - The Role of Genetic Screening in Cardiomyopathy: Who, When and Why, Cardiovascular Seminar, CVS.519. Challenges in the Diagnosis and Management of Cardiomyopathy., Tue, Nov 19, 5:30 - 6:45 PM
Tara Chang, Palo Alto, CA, Discussant of The Incidence of Kidney Injury for Patients Treated with Intensive versus Less Potent Statin Therapy after an Acute Coronary Syndrome , Clinical Science: Special Reports, CS.04. Advanced Cardiovascular Disease: Complications and Challenges, Wed, Nov 20, 10:45 a.m. - 12:15 p.m.
William Fearon, Stanford, CA, Adjuncts to Angiography , Early Career, EC.09. Interventional Cardiology Fellows Program, Sat, Nov 16, 1:00 - 5:00 p.m.
Michael Fischbein, Palo Alto, CA, Aortic Regurgitation Should Be Treated with the Gold Standard--AVR , Ask the Experts, ATE.603. Update on Aortic Valve Repair, Mon, Nov 18, 7:30 - 8:45 a.m.
Francois Haddad, Stanford, CA, Epidemiology of Pulmonary Hypertension Associated with Heart Failure , Ask the Experts, ATE.505. New Insights and Challenges in Pulmonary Hypertension with Left-Heart Failure, Tue, Nov 19, 5:30 - 6:45 p.m.
Robert Harrington, Stanford, CA, Navigating the 2013 AHA Scientific Sessions: Highlights and How to Make the Most Out of Your Meeting , Early Career, EC.02. Opening General Session (Part 1), Sat, Nov 16, 9:00 - 10:00 a.m.
Robert Harrington, Stanford, CA, Scientific Sessions Program Chair's Opening Remarks , Opening Session, OPS.01. Opening Session, Sun, Nov 17, 1:00 - 3:00 p.m.
Robert Harrington, Stanford, CA, Keynote: The Future of Academic Cardiovascular Medicine and Clinical Cardiology , Early Career, EC.12. How to Thrive as an Early Career Academic Cardiovascular Specialist (Planned by the Council on Clinical Cardiology), Sat, Nov 16, 1:00 - 2:00 p.m.
Mark Hlatky, Stanford, CA, Interpreting Cost-Effectiveness Analyses , Ask the Experts, ATE.204. Interpreting the Literature: A Primer on the Do's and Don'ts, Tue, Nov 19, 7:30 - 8:45 a.m.
Mark Hlatky, Stanford, CA, Cost-Effectiveness of the New Oral Anticoagulant Agents in Approved Indications , Plenary, PS.04. Novel Oral Anticoagulants: Clinical Conundra, Mon, Nov 18, 3:45 - 5:00 p.m.
Yasuhiro Honda, Stanford, CA, A Debate: OCT Is Not Yet as Clinically Valuable as IVUS , Ask the Experts, ATE.605. PCI Guided by OCT, IVUS and FFR: What You Need to Know, Mon, Nov 18, 9:00 - 10:15 a.m.
Sharon Hunt, Palo Alto, CA, Medical Challenges in the Treatment of VAD Patients , Cardiovascular Seminar, CVS.602. New Considerations in Destination VAD Therapy, Sun, Nov 17, 5:30 - 6:45 p.m.
Joshua Knowles, Stanford, CA, FH: A Public Health Perspective , Cardiovascular Seminar, CVS.312. Familial Hypercholesterolemia: Challenges and Opportunities, Tue, Nov 19, 5:30 - 6:45 p.m.
William Kuo, Stanford, CA, Strategies for Removing Difficult IVC Filters , Ask the Experts, ATE.613. Venous Thromboembolic Disease: When Do We Go Beyond Anticoagulation?, Tue, Nov 19, 5:30 - 6:45 p.m.
Kenneth W Mahaffey, Stanford, CA, Poster Professor , Abstract Poster Session, APS.717.01. Ischemic Heart Disease: Diagnosis and Prognosis, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Daria Mochly-Rosen, Stanford, CA, Protein Kinase C for Heart Disease Treatment: Challenges in Translation , Cardiovascular Seminar, CVS.508. Molecular Signaling in Cardiac Development and Diseases, Mon, Nov 18, 7:30 - 8:45 a.m.
Vinicio De Jesus Perez, Stanford, CA, New Insights in Genomics of Pulmonary Artery Hypertension , Cardiovascular Seminar, CVS.704. What Makes the Pulmonary Circulation Unique from the Systemic Circulation?, Sun, Nov 17, 5:30 - 6:45 p.m.
James Spudich, Stanford, CA, The Myosin Family of Molecular Motors: Nature's Exquisite Nanomachines , Special, SS.06. Lasker Awardee Lecture, Mon, Nov 18, 12:40 - 1:40 p.m.
Hong Jin, Karolinska Univ Hosp, Stockholm, Sweden; Katina M Wilson, Anil K Chauhan, The Univ of Iowa, Iowa City, IA; Philip S Tsao, Stanford Univ, Palo Alto, CA; Steven R Lentz, The Univ of Iowa, Iowa City, IA, 8794/ATVB17 - Apelin Protects Against Arterial Thrombosis in Mice with Diet-induced Obesity , Best of AHA Specialty Conferences, BASC.03. Best of AHA Specialty Conferences: ATVB 2013, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Jennifer Tremmel, Stanford, CA, Catheter Choices and Skills for Diagnostic and Interventional Procedures , Ask the Experts, ATE.608. Radial Access: Meet the Experts, Tue, Nov 19, 7:30 - 8:45 a.m.
Paul J Wang, Stanford, CA, Exercise Interventions After an ICD , Sunday Morning Program, SMP.402. Controversies in Hospital ECG Monitoring, Sun, Nov 17, 8:00 - 11:00 a.m.
Paul J Wang, Palo Alto, CA, Clinical Impact of the Subcutaneous ICD , Cardiovascular Seminar, CVS.415. Ventricular Fibrillation: From Bench to Bedside, Tue, Nov 19, 5:30 - 6:45 p.m.
Matthew Wheeler, Stanford, CA, Genomic Implications for Physical Activity , Cardiovascular Seminar, CVS.805ic. Physical Activity and Bench-to-Bedside Research: Cellular Discoveries and Implications for Clinical Practice, Tue, Nov 19, 7:30 - 8:45 a.m.
Ronald Witteles, Stanford, CA, Amyloidosis from Diagnosis to Management , Cardiovascular Seminar, CVS.519. Challenges in the Diagnosis and Management of Cardiomyopathy, Tue, Nov 19, 5:30 - 6:45 p.m.
Ronald Witteles, Stanford, CA, Cardiac Amyloidosis: Classification, Pathology and Clinical Presentation , Cardiovascular Seminar, CVS.527. Cardiac Amyloidosis and Infiltrative Disease: New Frontiers and Insights in Diagnosis and Management, Wed, Nov 20, 7:30 - 8:45 a.m.
Damelys Calderon, Inserm U633 and U1013, Paris, France; Matthieu Prot, Inserm U1013, Paris, France; Valerie Bellamy, Inserm U633, Paris, France; Patrick Bruneval, Dept of Pathology, Hôpital Européen Georges Pompidou, Univ Sorbonne Paris Cité, INSERM U 970, Paris, France; Joseph C. Wu, Stanford Univ Sch of Med, Palo Alto, CA; Michel Puceat, Inserm U633, Evry, France; Philippe Menasché, Dept of Cardiovascular Surgery, Hôpital Européen Georges Pompidou, Univ Sorbonne Paris Cité, INSERM U 633, Paris, France; Lucienne Chatenoud, Inserm U1013, Paris, France, 10901/7044 - CD3 Antibodies are a Promising Tool for Modulating the Immune Response to Embryonic Stem Cells and Their Cardiac Derivatives .
Joseph Wu, Stanford, CA, Imaging of Cardiac Stem Biology , Cardiovascular Seminar, CVS.107. Imaging in Potential Novel Therapies for Cardiovascular Diseases, Tue, Nov 19, 7:30 - 8:45 a.m.
Joseph Wu, Stanford, CA, Cardiovascular Disease Modeling Using hiPS Cells , Cardiovascular Seminar, CVS.502. Joint AHA/Progenitor Cell Biology Consortium Session: New Strategies for Myocardial Regeneration, Sun, Nov 17, 5:30 - 6:45 p.m.
Joseph Wu, Stanford, CA, Stem Cell Research and other Translational Research Approaches: Where are the Opportunities and Pitfalls for Young Investigators? , Early Career, EC.03. Opening General Session (Part 2) - New Paradigms and Opportunities in Cardiovascular Research for Clinical and Basic Science Researchers, Sat, Nov 16, 10:00 - 11:45 a.m.
Joseph Wu, Stanford, CA, iPS for Inherited Cardiomyopathies , Cardiovascular Seminar, CVS.518. iPS Cells in Cardiac Disease Modeling, Tue, Nov 19, 5:30 - 6:45 p.m.
Joseph Wu, Stanford, CA, Genome Editing in Stem Cells and Induced Pluripotent Cells , Sunday Morning Program, SMP.507. The Best of Circulation Research Symposium, Sun, Nov 17, 8:00 - 11:00 a.m.
Sean M Wu, Stanford, CA, Mesodermal Cardiac Differentiation , Sunday Morning Program, SMP.507. The Best of Circulation Research Symposium, Sun, Nov 17, 8:00 - 11:00 a.m.
Sean M Wu, Stanford, CA, Human Myocyte Turnover , Cardiovascular Seminar, CVS.513. Cardiomyocyte Renewal, Mon, Nov 18, 5:30 - 6:45 p.m.
Marco V Perez, Aleksandra Pavlovic, Matthew T Wheeler, Clint L. Miller, Porama Thanaporn, Frederick E. Dewey, Stephen Pan, Stanford Univ, Stanford, CA; Devin Absher, Hudson Alpha Inst for Biotechnology, Huntsville, AL; Elizabeth Cretti, Audrey Southwick, Paul Heidenreich, Daniel Sedehi, Stanford Univ, Stanford, CA; Jeffrey Brandimarto, Stanford Univ, Philadelphia, PA; David Kao, Stanford Univ, Denver, CO; Heidi Salisbury, Khin Chan, David Rosenthal, Daniel Bernstein, Michael B. Fowler, Robert C. Robbins, Richard Meyers, Richard Meyers, Thomas Quertermous, Stanford Univ, Stanford, CA; Thomas Cappola, Stanford Univ, Philadelphia, CA; Euan Ashley, Stanford Univ, Stanford, CA, 16018 - Genetic Variation Near HCRTR2 Associates With Dramatic Improvement of Heart Function in Patients With Heart Failure , Abstract Oral Session, AOS.300.02Y. Functional Genomics and Translational Biology Young Investigator Award Finalists, Sun, Nov 17, 3:45 - 4:45 p.m.
Fabian C Emrich, Homare Okamura, Alex R Dalal, Stanford Univ, Stanford, CA; Denis R Merk, Leipzig Univ, Leipzig, Germany; Uwe Raaz, Jan K Hennigs, Jocelyn T Chin, Miquell O Miller, Francis G Blankenberg, Andrew J Connolly, Cristina M Alvira, Stanford Univ, Stanford, CA; Friedrich W Mohr, Leipzig Univ, Leipzig, Germany; Robert C Robbins, Michael P Fischbein, Stanford Univ, Stanford, CA, 15289 - Apoptosis Participates in Early Aneurysm Development via ECM Remodeling in Marfan Syndrome , Abstract Oral Session, AOS.607.01. Thoracic Aortic Disease I, Mon, Nov 18, 2:00 - 5:10 p.m.
June-Wha Rhee, Naga L Sudini, Michael Pham, William Fearon, David Lee, Ramin E Beygui, Jose G Montoya, Joseph Wu, Bojan Vrtovec, Sharon A Hunt, François Haddad, Stanford Hosp & Clinics, Stanford, CA, 18326 - Elevated Right Ventricular Operant Diastolic Elastance Strongly Predicts Increased Risk of Mortality Following Heart Transplantation , Abstract Oral Session, AOS.507.01. Promoting Survival Following MCS and Heart Transplantation, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Nicholas M Mordwinkin, Mingxia Gu, Nigel G Kooreman, Shijun Hu, Jared M Churko, Sebastian Diecke, Paul W Burridge, Chunjiang He, Jaechol Lee, Joseph D Gold, Joseph Wu, Stanford Univ, Stanford, CA, 16710 - Induced Pluripotent Stem Cell-Derived Endothelial Cells From Diet-Induced Obesity Mice Exhibit Decreased Vascular Function in a Murine Model of Hindlimb Ischemia , Abstract Oral Session, AOS.705.01F. Optimizing Stem Cell Repair in Models of Disease, Mon, Nov 18, 9:00 a.m. - 12:00 p.m.
Hideki Kitahara, Ryotaro Yamada, Kenji Sakamoto, Katsuhisa Waseda, Paul G Yock, Alan C Yeung, Hannah A Valantine, William Fearon, Peter J Fitzgerald, Yasuhiro Honda, Stanford Univ, Stanford, CA, 15998 - Relation Between Periarterial Neovascularization and Progression of Coronary Allograft Vasculopathy: A Serial IVUS Study of Cardiac Transplant Patients , Abstract Oral Session, AOS.606.01. Vulnerable Plaque, Drug-Eluting Stents: Insights from Advanced Coronary Imaging and Physiology, Mon, Nov 18, 2:00 - 5:10 p.m.
Sang-Ging Ong, Mei Huang, Won Hee Lee, Devaveena Dey, Joseph Wu, Stanford Univ, Stanford, CA, 16862 - Transfer of Exosome-Enclosed MicroRNAs From Host Myocardial Cells to Transplanted Cardiac Stem Cells Facilitates Improved Survival in the Ischemic Myocardium , Abstract Oral Session, AOS.502.01. Novel Cell, Tissue Engineering and Gene-Based Strategies for Heart Failure, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Rajesh Dash, Aditya Subramanian, Yuka Matsuura, Il Suk Sohn, Ting-Yuan Yeh, Michael V McConnell, Joseph Wu, Phillip C Yang, Stanford Univ Medical Ctr, Stanford, CA, 16618 - Manganese-Enhanced MRI Enables Longitudinal in vivo Tracking of Transplanted Stem Cell Viability in the Murine Myocardium , Abstract Oral Session, AOS.108.02. Cardiac MR Imaging II, Mon, Nov 18, 2:00 - 5:10 p.m.
Joshua W Knowles, Stanford, Stanford, CA; Ke Hao, Mount Sinai Sch of Med, New York, NY; Weija Xie, Michael N Weedon, Univ of Exeter Medical SChool, Exeter, United Kingdom; Zhongyang Zhang, Mount Sinai Sch of Med, New York, NY; Jussi Paananen, Univ of Eastern Finland, Kuopio, Finland; Mark O Goodarzi, Cedars-Sinai Medical Ctr, West Hollywood, CA; Ola Hansson, Lund Univ, Malmo, Sweden; James S. Pankow, Univ of Minnesota, Minneapolis, MN; Indumathi Chenemsetty, Ivan Carcamo-Orive, Themistocles Assimes, Stanford, Stanford, CA; Andrew Morris, Uppsala Univ, Uppsala, Sweden; Yii-Der I Chen, Harbor-UCLA Medical Ctr, Torrance, CA; Eric E Schadt, Mount Sinai Sch of Med, New York, NY; Ville-Petteri Mäkinen, Xia Yang, Univ of California, Los Angeles, Los Angeles, CA; Fahim Abbasi, Stanford, Stanford, CA; Alan Attie, Mark Keller, Univ of Wisconsin - Madison, Madison, WI; Danielle Greenawalt, Merck, Boston, MA; The GENESIS, RISC, EUGENE2, ULS a.m., GUARDIAN and SAPPHIRe Consortia; Jerome I Rotter, UCLA, Torrance, CA; Alan Sinaiko, Univ of Minnesota, Minneapolis, MN; Agnes Hsiung, Natl Health Res Insts, Zhunan Town, Taiwan; Heather J Cordell, Newcastle Univ, Newcastle upon Tyne, United Kingdom; Gerald Reaven, Stanford, Stanford, CA; Leif Groop, Lund Univ, Malmö, Sweden; Markku Laakso, Univ of Eastern Finland, Kuopio, Finland; Erik Ingelsson, Uppsala Univ, Uppsala, Sweden; Timothy M Frayling, Univ of Exeter Medical SChool, Exeter, United Kingdom; Mark Walker, Newcastle Univ, Newcastle upon Tyne, United Kingdom; Thomas Quertermous, Stanford, Stanford, CA, 10906 - Genetic and Functional Analyses Identify NAT2 as a Human Insulin Sensitivity Gene , Abstract Oral Session, AOS.304.01F. Common and Rare Variants Associated with CAD and Risk Factors, Mon, Nov 18, 2:00 - 5:00 p.m.
Raiyan Zaman, Stanford Univ Sch of Med, Palo Alto, CA; Hisanori Kosuge, Stanford Univ Sch of Med, Stanford, CA; Guillem Pratx, Stanford Univ Sch of Med, Palo Alto, CA; Colin Carpenter, Lei Xing, Michael V McConnell, Stanford Univ Sch of Med, Stanford, CA, 12212 - Atherosclerotic Plaque Detection With a Fluorescence/Radionuclide Intravascular Imaging System for 18F-FDG and 6-NBDG , Abstract Oral Session, AOS.100.01Y. Melvin Judkins Young Investigator Award Finalists, Sun, Nov 17, 3:45 - 5:00 p.m.
Ke Yuan, Mark Orcholski, Cristina Panaroni, Joy Wu, Vinicio de Jesus Perez, Stanford Univ, Stanford, CA, 15706 - Loss of Wnt/Ror2 Signaling is Associated With Reduced Pericyte Recruitment and Impaired Pulmonary Angiogenesis in Idiopathic Pulmonary Arterial Hypertension , Abstract Oral Session, AOS.723.01. Novel Signaling Pathways of Pulmonary Hypertension, Tue, Nov 19, 2:00 - 5:10 p.m.
Yohannes T Ghebremariam, Lawrence Ho, Glenn D Rosen, John P Cooke, Stanford Univ, Stanford, CA, 9843 - Proton Pump Inhibitors Inhibit DDAH and Processes Underlying Idiopathic Pulmonary Fibrosis , Abstract Oral Session, AOS.400.01Y. Cournand and Comroe Young Investigator Prize Finalists, Sun, Nov 17, 3:45 - 5:00 p.m.
Sina Jamé, Stanford Univ Sch of Med, Stanford, CA; Valentina Kutyifa, Scott McNitt, Univ of Rochester Medical Ctr, Rochester, NY; Amin Al-Ahmad, Stanford Univ Sch of Med, Stanford, CA; Mehmet Aktas, Wojciech Zareba, Arthur Moss, Univ of Rochester Medical Ctr, Rochester, NY; Paul J. Wang, Stanford Univ Sch of Med, Stanford, CA, 10856 - Prognostic Significance of Left Ventricular Lead Pacing Polarity in CRT-D Patients - A MADIT-CRT Substudy , Abstract Oral Session, AOS.505.01. Heart Failure: Pacing, Outcomes and Future Device Interventions, Mon, Nov 18, 9:00 a.m. - 12:10 p.m.
Muhammad Soofi, The Ohio State Univ Coll of Med, Columbus, OH; Alexander Perino, Stanford Univ, Stanford, CA; Nikhil Singh, Univ at Buffalo school of Med and Biomedical Sciences, Buffalo, NY; Sonya Aggarwal, Stanford Univ, Palo Alto, CA; Victor F. Froelicher, Stanford Univ Sch of Med, Palo Alto, CA, 14658 - Do the New ECG Criteria for ST Elevation MI (STEMI) Result in Too Many Low Risk Patients Being Considered for Coronary Reperfusion Therapy? , Abstract Oral Session, AOS.715.01. Unstable Angina, NSTEMI and STEMI: Diagnosis and Pathophysiology, Mon, Nov 18, 2:00 - 5:10 p.m.
Anuradha Phadke, Paul Heidenreich, Stanford Hosp, Stanford, CA, 16849 - Factors Associated With DNR Status Among Patients Hospitalized for Heart Failure in California , Abstract Oral Session, AOS.506.01. Heart Failure: Clinical Outcomes and Comorbid Conditions, Mon, Nov 18, 9:00 a.m. - 12:10 p.m.
Gregor Poglajen, Matjaz Sever, UMC Ljubljana, Ljubljana, Slovenia; Polonca Mali, Natl Blood Transfusion Inst, Ljubljana, Slovenia; Francois Haddad, Joseph Wu, Stanford Univ Sch of Med, Stanford, CA; Bojan Vrtovec, UMC Ljubljana, Ljubljana, Slovenia, 17230 - Effects of Transendocardial CD34+ Stem Cell Transplantation in Patients With Ischemic Cardiomyopathy , Abstract Oral Session, AOS.502.01. Novel Cell, Tissue Engineering and Gene-Based Strategies for Heart Failure, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Sarvjeet Singh, Diana Canseco, David Grinsfelder, lldiko Bock-Marquette, Shandon C Collins, UT Southwestern medical center at Dallas, Dallas, TX; Pilar Ruiz-Lozano, Stanford Univ, Stanford, CA; Beverly A Rothermel, Pradeep PA Mammen, UT Southwestern medical center at Dallas, Dallas, TX, 11639 - Cytoglobin: A Novel Epicardial Regulator of Epithelial to Mesenchymal Transition (EMT) Within the Ischemic Heart , Abstract Oral Session, AOS.501.02. Fibroblast Modulation in Cardiac Remodeling, Tue, Nov 19, 9:00 - 11:55 a.m.
Luciana Armaganijan, Brazilian Clinical Res Inst, São Paulo, Brazil; Renato Lopes, Zhen Huang, Pierluigi Tricoci, Duke Clinical Res Inst, Durham, NC; Claes Held, Uppsala Clinical Res Ctr, Uppsala Univ, Uppsala, Sweden; Frans Van de Werf, Univ Hosp Leuven, Leuven, Belgium; Paul W Armstrong, Univ of Alberta, Edmonton, AB, Canada; Philip E Aylward, SAHMRI, Flinders Univ and Medical Ctr, Adelaide, Australia; Harvey D White, Green Lane Cardiovascular Service, Auckland, New Zealand; David J Moliterno, Gill Heart Inst and Univ of Kentucky, Lexington, KY; Lars Wallentin, Uppsala Clinical Res Ctr, Uppsala Univ, Uppsala, Sweden; Edmond Chen, Merck, Whitehouse Station, NJ; Robert A Harrington, Stanford Univ, Stanford, CA; John Strony, Merck, Whitehouse Station, NJ; Kenneth W Mahaffey, Stanford Univ, Stanford, CA, 13198 - Efficacy and Safety of Vorapaxar in Elderly Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Insights From the TRACER Trial , Abstract Oral Session, AOS.716.01N. Laennec Clinician/Educator Lecture and New Developments in the Treatment of Patients with Non--ST-Elevation ACS, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Ralf E Harskamp, John H Alexander, Phillip J Schulte, Duke Clinical Res Inst, Durham, NC; Colleen M Brophy, Vanderbilt Univ Medical Ctr, Nashville, TN; Michael J Mack, CRSTI, Dallas, TX; Eric D Peterson, Judson B Williams, Duke Clinical Res Inst, Durham, NC; C. Michael Gibson, PERFUSE, Boston, MA; Robert M Califf, Duke Translational Med Inst, Durham, NC; Nicholas T Kouchoukos, Missouri Baptist Medical Ctr, St Louis, MO; Robert A Harrington, Stanford Univ, Stanford, CA; T Bruce Ferguson Jr, East Carolina Univ, Durham, NC; Renato D Lopes, Duke Clinical Res Inst, Durham, NC, 14160 - Preservation Solutions, Patency, and Outcomes After Coronary Bypass Surgery , Abstract Oral Session, AOS.608.01. Surgical Revascularization for Ischemic Heart Disease I, Mon, Nov 18, 2:00 - 5:10 p.m.
Sharif Halim, Qinghong Yang, Phillip Schulte, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; Judith Hochman, New York Univ Sch of Med, New York, NY; Chiara Melloni, Kenneth W Mahaffey, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; David J Moliterno, Gill Heart Inst and Univ of Kentucky, Lexington, KY; Robert A Harrington, Stanford Univ, Stanford, CA; Harvey D White, Green Lane Cardiovascular Service, Auckland, New Zealand; Paul W Armstrong, Univ of Alberta, Edmonton, AB, Canada; E. Magnus Ohman, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; Frans Van de Werf, Univ Hosp Leuven, Leuven, Belgium; Robert P Giugliano, TIMI Study Group, Brigham and Women’s Hosp, Boston, MA; L. Kristin Newby, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC, 15834 - Evolution of Differences in Women and Men With Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From Clinical Trials Over 15 Years , Abstract Oral Session, AOS.716.01N. Laennec Clinician/Educator Lecture and New Developments in the Treatment of Patients with Non--ST-Elevation ACS, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Weston W Whittington, Muhanad Al-Zubaidi, Roger Tseng, Banner Good Samaritan Hosp, Phoenix, AZ; Paul Wang, Stanford Univ, Stanford, CA; Wilber Su, Banner Good Samaritan Hosp, Phoenix, AZ, 17075 - Second Generation Cryoballoon Ablation With Improved Freezing Results in Pulmonary Injury and Unexpected Late Adhesion , Abstract Oral Session, AOS.406.01. Techniques/Technologies to Improve AF Ablation, Tue, Nov 19, 2:00 - 5:10 p.m.
Misa Fister, Ursa Mikuz, UMC Ljubljana, Ljubljana, Slovenia; Vito Starc, Univ of Ljubljana Sch of Med, Ljubljana, Slovenia; Francois Haddad, Stanford Univ Sch of Med, Stanford, CA; Bojan Vrtovec, UMC Ljubljana, Ljubljana, Slovenia, 17297 - Heart Rate-Guided Titration of Beta Blockers Stabilizes Ventricular Repolarization in Patients With Chronic Heart Failure , Abstract Oral Session, AOS.504.01. Heart Failure: Neurohormonal Therapy Revisited, Tue, Nov 19, 2:00 - 5:10 p.m.
Pierluigi Tricoci, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; Edmond Chen, Merck, Whitehouse Station, NJ; Megan L Neely, Duke Clinical Res Inst, Durham, NC; Amelia Warner, Peggy H Wong, Merck, Whitehouse Station, NJ; Peter Sinnaeve, Univ Hosp Leuven, Leuven, Belgium; Lars Wallentin, Uppsala Clinical Res Ctr, Uppsala Univ, Uppsala, Sweden; Lisa K Jennings, CirQuest Labs, LLC, Memphis, TN, USA and Univ of Tennessee Health Science Ctr, Memphis, TN; Robert F Storey, Univ of Sheffield, Sheffield, United Kingdom; Phillip E Aylward, SAHMRI, Flinders Univ and Medical Ctr, Adelaide, Australia; Harvey D White, Green Lane Cardiovascular Service, Auckland, New Zealand; Frans Van de Werf, Univ Hosp Leuven, Leuven, Belgium; Paul W Armstrong, Univ of Alberta, Edm, AB, Canada; Claes Held, Uppsala Clinical Res Ctr, Uppsala Univ, Uppsala, Sweden; Marco Valgimigli, A.O. Univria di Ferrara, Ferrara, Italy; Robert A Harrington, Stanford Univ, Stanford, CA; John Strony, Merck, Whitehouse Station, NJ; Kenneth W Mahaffey, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; David J Moliterno, Gill Heart Inst and Univ of Kentucky, Lexington, KY, 17658 - CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial , Abstract Oral Session, AOS.716.01N. Laennec Clinician/Educator Lecture and New Developments in the Treatment of Patients with Non--ST-Elevation ACS, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Brian R. Lindman, Washington Univ Sch of Med, St. Louis, MO; William Stewart, Cleveland Clinic Fndn, Cleveland, OH; Philippe Pibarot, Laval Univ, Quebec, QC, Canada; Rebecca T. Hahn, Columbia Univ Medical Ctr, New York, NY; Neil J. Weissman, Medstar Health Res Inst, Columbia, MD; Thomas C. McAndrew, Cardiovascular Res Fndn, New York, NY; Wilson Y. Szeto, Hosp of the Univ of Pennsylvania, Philadelphia, PA; Raj Makkar, Cedars-Sinai Medical Ctr, Los Angeles, CA; D. Craig Miller, Stanford Univ Sch of Med, Stanford, CA; Vasilis Babaliaros, Emory Univ Sch of Med, Atlanta, GA; Samir Kapadia, Cleveland Clinic Fndn, Cleveland, OH; Bruce Bowers, Medical City Dallas, Dallas, TX; Kevin L. Greason, Mayo Clinic, Rochester, MN; Martin B. Leon, Columbia Univ Medical Ctr, New York, NY; Maurice Sarano, Mayo Clinic, Rochester, MN; Richard B. Devereux, Weill Cornell New York Presbyterian Hosp, New York, NY; Catherine M Otto, Univ of Washington, Seattle, WA; Pamela S. Douglas, Duke Univ Duke Univ Medical Ctr, and Duke Clinical Res Inst, Durham, NC, 18185 - Regression of Severe Left Ventricular Hypertrophy After Transcatheter Valve Replacement for Aortic Stenosis: Impact on Clinical Outcomes in PARTNER Cohort A , Abstract Oral Session, AOS.605.01F. New Developments in TAVR and Complex Structural Heart Interventions, Mon, Nov 18, 9:00 a.m. - 12:20 p.m.
Daniela Farkas, Aysar A Alhussaini, Donatas Kraskauskas, Vita Kraskauskiene, Virginia Commonwealth Univ, Richmond, VA; Mark R Nicolls, Stanford Univ, Stanford, CA; Norbert F Voelkel, Ramesh Natarajan, Laszlo Farkas, Virginia Commonwealth Univ, Richmond, VA, 9814 - Nf-κB Inhibition Prevents Vascular Obliteration and Improves Immune Regulation in Severe Pulmonary Arterial Hypertension , Abstract Oral Session, AOS.508.01. Disorders of Pulmonary Circulation: Bench to Bedside, Mon, Nov 18, 2:00 - 5:10 p.m.
Celina Yong, Xiangyan Xu, Claire Than, Aditya Ullal, Susan Schmitt, Farnaz Azarbal, Paul Heidenreich, Mintu Turakhia, VA Palo Alto Healthcare System, Palo Alto, CA, 14134 - Racial Disparities in Warfarin Time in INR Therapeutic Range in Patients With Atrial Fibrillation: Findings From the TREAT-AF Study , Abstract Oral Session, AOS.213.01. Atrial Fibrillation, Stroke and Anticoagulant Strategies: Real-World Delivery of Care and Outcomes, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Cynthia Jackevicius, Western Univ, Pomona, CA; Meytal Avgil, McGill Univ, Montreal, QC, Canada; Jack Tu, Inst for Clinical Evaluative Sciences, Toronto, ON, Canada; Vidal Essebag, Mark Eisenberg, McGill Univ, Montreal, QC, Canada; Clare Atzema, Inst for Clinical Evaluative Sciences, Toronto, ON, Canada; Michael Ho, Denver VA Medical Ctr, Denver, CO; Mintu Turakhia, VA Palo Alto, Stanford, CA; Lingyun Lu, Western Univ, Pomona, CA; Hassan Behlouli, Western Univ, Montreal, QC, Canada; Louise Pilote, McGill Univ, Montreal, QC, Canada, 15620 - Adherence With Dabigatran Therapy in Patients With Atrial Fibrillation , Abstract Oral Session, AOS.213.01. Atrial Fibrillation, Stroke and Anticoagulant Strategies: Real-World Delivery of Care and Outcomes, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Benjamin A Steinberg, Duke Univ Medical Ctr, Durham, NC; Sunghee Kim, Duke Clinical Res Inst, Durham, NC; Gregg C Fonarow, Univ of California, Los Angeles, Los Angeles, CA; Laine Thomas, Duke Clinical Res Inst, Durham, NC; Jack Ansell, Lenox Hill Hosp, New York, NY; Peter R Kowey, MLH Heart Ctr, Wynnewood, PA; Kenneth W Mahaffey, Duke Univ Medical Ctr, Durham, NC; Bernard Gersh, May Clinic, Rochester, MN; Elaine Hylek, Boston Univ Medical Ctr, Boston, MA; Paul Chang, Janssen Pharmaceuticals, LLC, Raritan, NJ; Eric D Peterson, Jonathan P Piccini, Duke Univ Medical Ctr, Durham, NC. 10215 - Predictors of Cause- Specific Hospitalization in US Outpatients With Atrial Fibrillation: Results From the ORBIT-AF Study. Abstract Oral Session AOS.213.01. Atrial Fibrillation, Stroke and Anticoagulant Strategies: Real-World Delivery of Care and Outcomes.
Jonathan P Piccini, Jyotsna Garg, Manesh R Patel, Yuliya Lokhnygina, Duke Clinical Res Inst, Durham, NC; Shaun G Goodman, Canadian Heart Res Ctr and Terrence Donnelly Heart Ctr,, Toronto, ON, Canada; Richard C Becker, Duke Clinical Res Inst, Durham, NC; Scott D Berkowitz, Bayer HealthCare Pharmaceuticals, Montville, NJ; Gunter Breithardt, Hosp of the Univ of Munster, Munster, Germany; Werner Hacke, Ruprecht-Karls-Univ, Heidelberg, Germany; Jonathan L Halperin, The Cardiovascular Inst, New York, NY; Graeme J Hankey, Sch of Med and Pharmacology, The Univ of Western Australia, and Stroke Unit, Royal Perth Hosp, Perth, Australia; Christopher C Nessel, Janssen Res & Development, Raritan, NJ; Kenneth W Mahaffey, Duke Clinical Res Inst, Durham, NC; Daniel E Singer, Massachusetts General Hosp and Harvard Medical Sch, Boston, MA; Robert M Califf, Duke Translational Med Inst, Durham, NC; Keith AA Fox, Univ of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, United Kingdom. 15879 - Management of Major Bleeding Events in Patients Treated With Rivaroxaban Versus Warfarin: Results From the ROCKET AF Trial. Abstract Oral Session AOS.405.01. Dilemmas in the Anticoagulation of Atrial Fibrillation Tue, Nov 19, 9:00 AM - 12:10 PM
Renato D Lopes, Duke Clinical Res Inst, Durham, NC; DaJuanicia N Holmes, Duke Clinical Res Inst, Duke Univ Medical Ctr, Durham, NC; Laine Thomas, Duke Clinical Res Inst, Durham, NC; Jack Ansell, NYU Sch of Med, New York, NY; Gregg C Fonarow, UCLA, Los Angeles, CA; Bernard J Gersh, Mayo Clinic, Rochester, MN; Alan S Go, Kaiser Permanente Northern California, Oakland, CA; Elaine M Hylek, Boston Univ, Boston, MA; Peter R Kowey, Lankenau Inst for Medical Res and Jefferson Medical Coll, Wynnewood, PA; Jonathan P Piccini, Duke Clinical Res Inst, Durham, NC; Daniel E Singer, Massachusetts General Hosp and Harvard Medical Sch, Boston, MA; Paul Chang, Janssen Pharmaceuticals, Inc., Raritan, NJ; Eric D Peterson, Kenneth W Mahaffey, Duke Clinical Res Inst, Durham, NC. 15956 - Triple Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and History of Coronary Artery Disease: Insights From the ORBIT-AF Registry. Abstract Oral Session AOS.405.01. Dilemmas in the Anticoagulation of Atrial Fibrillation Tue, Nov 19, 9:00 AM - 12:10 PM
Sushma Reddy. miR-21 is a Biomarker for Fibrosis and the Progression to Right Ventricular Systolic Failure in a Model of Pulmonary Volume and Pressure Overload. miR-21 is a Biomarker for Fibrosis and the Progression to Right Ventricular Systolic Failure in a Model of Right Ventricular Volume and Pressure Overload. Abstract oral. AOS.305.05h Free Pulmonary Insufficiency and Other Daily Problems. Tuesday, November 19, 2013, 9:00 am - 12:10 pm. Ballroom A1.
Frederick Dewey, Stanford, CA, 21507 - Discussant , Abstract Oral Session, AOS.303.01. Multiscale Omics Reveals New Mechanisms of Cardiovascular Disease, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Vinicio De Jesus Perez, Stanford, CA, 21623 - Discussant , Abstract Oral Session, AOS.723.01. Novel Signaling Pathways of Pulmonary Hypertension, Tue, Nov 19, 2:00 - 5:10 p.m.
Mintu Turakhia, Palo Alto, CA, Discussant , Abstract Oral Session, AOS.213.01. Atrial Fibrillation, Stroke and Anticoagulant Strategies: Real-World Delivery of Care and Outcomes, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Mintu Turakhia, Palo Alto, CA, Discussant , Abstract Oral Session, AOS.213.01. Atrial Fibrillation, Stroke and Anticoagulant Strategies: Real-World Delivery of Care and Outcomes, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Joseph Wu, Stanford, CA, 21543 - Discussant , Abstract Oral Session, AOS.502.01. Novel Cell, Tissue Engineering and Gene-Based Strategies for Heart Failure, Tue, Nov 19, 9:00 a.m. - 12:10 p.m.
Michael Fischbein, Palo Alto, CA, 19784 - Poster Professor , Abstract Poster Session, APS.608.01. Surgical Revascularization for Ischemic Heart Disease II, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
Michael Fischbein, Palo Alto, CA, 20583 - Poster Professor , Abstract Poster Session, APS.610.01. Surgical Therapy for Valvular Heart Disease I, Sun, Nov 17, 9:00 a.m. - 5:00 p.m.
Dominik Fleischmann, Stanford, CA, 21171 - Poster Professor , Abstract Poster Session, APS.107.01. Noncoronary CT Imaging, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Daniel Murphy, Palo Alto, CA, 21127 - Poster Professor , Abstract Poster Session, APS.309.02h. Adult Congenital Heart Disease: Predictors of Outcome and Implications of Fontan, Wed, Nov 20, 9:00 a.m. - 12:00 p.m.
Kenji Sakamoto, Katsuhisa Waseda, Hideki Kitahara, Ryotaro Yamada, Ching-Chang Huang, Takao Shimohama, Masao Yamasaki, Ichizo Tsujino, Akiyoshi Miyazawa, Daisaku Nakatani, Kenji Sakata, Osami Kawarada, Paul G Yock, Stanford Univ Medical Ctr, Stanford, CA; Krishnankutty Sudhir, Abbott Vascular, Santa Clara, CA; Peter J Fitzgerald, Yasuhiro Honda, Stanford Univ Medical Ctr, Stanford, CA, 14197/2083 - Effects of Metabolic Syndrome on Arterial Responses to Drug-Eluting Stents: Obesity Paradox and Sex-Associated Differences , Abstract Poster Session, APS.209.04h. Impact of Obesity on Cardiac Structure and Function, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Sang-Ging Ong, Bruno C Huber, Antje Ebert, Kazuki Kodo, Joseph D Gold, Robert C Robbins, Joseph Wu, Stanford Univ, Stanford, CA, 16925/5023 - In Vivo Crosstalk Between Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Host Myocardial Cells , Abstract Poster Session, APS.502.04. Tissue-Engineered and Cellular Therapies for Cardiomyopathy, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
Johannes Riegler, Qi Shen, Steve T. Yeh, Mei Huang, Joseph D. Gold, Jospeh C. Wu, Stanford Univ, Stanford, CA, 13166/5050 - Novel Heart Tissue Slice Enables Long-term Survival and Engraftment Following Transplantation in Ischemic Hearts , Abstract Poster Session, APS.502.02. Cell and Tissue Engineering Therapies for Heart Failure, Sun, Nov 17, 9:00 a.m. - 5:00 p.m.
Sebastian J Caliri, Frederick E. Dewey, Megan E. Grove, James Priest, Suyash Shringarpure, Cuiping Pan, Somalee Datta, Stanford Univ, Stanford, CA; Megan J. Puckelwartz, Jessica R. Golbus, Univ of Chicago, Chicago, IL; Michael Snyder, Carlos D. Bustamante, Stanford Univ, Stanford, CA; Sharlene Day, Univ of Michigan, Ann Arbor, MI; Elizabeth McNally, Univ of Chicago, Chicago, IL; Thomas Cappola, Univ of Pennsylvania, Philadelphia, PA; Gerald Dorn, Washington Univ in St. Louis, St. Louis, MO; Euan A. Ashley, Stanford Univ, Stanford, CA, 22184/LBBS09 - Rare Variation in Sarcomeric Genes Accompanies MYH7 Hypertrophic Cardiomyopathy , Abstract Poster Session, LBS.02. Late-Breaking Basic Science Posters and Reception, Mon, Nov 18, 5:00 - 7:00 p.m.
Kyuhachi Otagiri, Kenji Sakamoto, Ryotaro Yamada, Hideki Kitahara, Shigemitsu Tanaka, Paul G. Yock, Peter J. Fitzgerald, Yasuhiro Honda, Stanford Univ, Stanford, CA, 15943/6003 - Impact of Stent Patency on Proximal and Distal Vessel Segments After Various Drug-Eluting Stent Implantation: Pooled Intravascular Ultrasound Analyses , Abstract Poster Session, APS.602.01. Next Generation Stents, Polymers and Approaches, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Elizabeth Choe, Suman Nag, Jongmin Sung, Ruth Sommese, Shirley Sutton, James A Spudich, Kathleen Ruppel, Stanford Univ, Stanford, CA, 12207/5026 - S532P Mutation in Human β-Cardiac Myosin Heavy Chain Decreases Contractile Force by Decreasing the Intrinsic Force of the Myosin Motor , Abstract Poster Session, APS.501.03. Contractile Proteins and Key Signaling Molecules in Heart Failure, Sun, Nov 17, 9:00 a.m. - 5:00 p.m.
Shigemitsu Tanaka, Ryotaro Yamada, Jennifer A Tremmel, Ingela Schnittger, Paul G Yock, Peter J Fitzgerald, Yasuhiro Honda, Stanford Univ Medical Ctr, Stanford, CA, 17154/5151 - Impact of Myocardial Bridging on Coronary Endothelial Dysfunction and Atherosclerotic Plaque Formation , Abstract Poster Session, APS.518.02. Potpourri of Left Ventricular Function, Myocarditis and Pericarditis, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
Bong-Ki Lee, Kangwon Natl Univ Hosp/Stanford Univ Med Ctr, Chuncheon, Korea, Republic of; Andy C. Yong, William F. Fearon, Stanford Univ Medical Ctr, Stanford, CA; Hong-Seok Lim, Ajou Univ Hosp/Stanford Univ Med Ctr, Suwon, Korea, Republic of; Patricia K. Nguyen, Alan C. Yeung, Jennifer A. Tremmel, Stanford Univ Medical Ctr, Stanford, CA, 19113/6044 - Invasive Evaluation of Chest Pain in Patients With Angiographically Normal Coronary Arteries , Abstract Poster Session, APS.606.01. Catheter-Based Coronary Imaging and Hemodynamics I, Sun, Nov 17, 9:00 a.m. - 5:00 p.m.
Sanna Vattulainen, Univ of Helsinki, Helsinki, Finland; Minna M. Koskenvuo, Caiyun Grace Li, Stanford Univ Sch of Med, Stanford, CA; Molong Li, The Johns Hopkins Univ, Baltimore, MD; Vinicio de Jesus Perez, Cristina Alvira, Hirofumi Sawada, Stanford Univ Sch of Med, Stanford, CA; Juha W. Koskenvuo, Univ of Turku, Turku, Finland; Marlene Rabinovitch, Stanford Univ Sch of Med, Stanford, CA; Tero-Pekka Alastalo, Univ of Helsinki, Helsinki, Finland, 18396/7054 - Peroxisome Proliferator-Activated Receptor Gamma- Deficiency in Endothelial Cells Leads to Impaired Angiogenesis , Abstract Poster Session, APS.706.02. Novel Mechanisms and Therapeutics in Angiogenesis Part II, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
Homare Okamura, Fabian Emrich, Alex Dalal, Andrew Connolly, Michael Fischbein, Stanford Univ, Stanford, CA, 17761/6068 - Long-term microRNA-29b Suppression Prevents Aneurysm Development in Marfan Syndrome Model Mouse , Abstract Poster Session, APS.607.01. Thoracic Aortic Disease I, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
Anthony C Sturzu, Rajarajan Kuppusamy, Stanford Univ, Stanford, CA; Derek Passer, Alyssa K Riley, Timothy C Tan, Massachusetts General Hosp, Boston, MA; Marc C Engles, Stanford Univ, Stanford, CA; Rebecca Feistritzer, Keston D Robertson, Marielle Scherrer-Crosbie, Ibrahim J Domian, Massachusetts General Hosp, Boston, MA; Sean M Wu, Stanford Univ, Stanford, CA, 12609/9005 - A Novel Cell Ablation Strategy Defines the Regenerative Potential of the Embryonic Mouse Heart , Abstract Poster Session, APS.901.01. Best of Basic Science Abstracts and Reception, Mon, Nov 18, 5:00 - 7:00 p.m.
Björn Hartmann, Shalini V Mohan, Jörg J Goronzy, Cornelia M Weyand, Stanford Univ Sch of Med, Stanford, CA, 14947/7071 - JAK/STAT-Signaling in Giant Cell Arteritis , Abstract Poster Session, APS.707.01. Inflammation and Adhesion Molecules I, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
Hyun Seok Hwang, Dmytro O. Kryshtal, Vanderbilt Univ, Nashville, TN; Verónica Sánchez-Freire, Stanford Univ, Stanford, CA; Tromondae K. Feaster, Vanderbilt Univ, Nashville, TN; Jianhua Zhang, Timothy J. Kamp, Univ of Wisconsin, Madison, WI; Charles C. Hong, Vanderbilt Univ, Nashville, TN; Joseph C. Wu, Stanford Univ, Stanford, CA; Bjorn C. Knollmann, Vanderbilt Univ, Nashville, TN, 16982/4016 - Human Cardiomyocytes Generated From Muliple iPS Cell Lines Exhibit Mature Calcium Handling , Abstract Poster Session, APS.402.01. Stem Cell-Derived Cardiomyocyte Models of Arrhythmia, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
James R Priest, Stanford Univ Medical Ctr, Stanford, CA; Santhosh Girirajan, Pennsylvania State Univ, College Station, PA; Frederick Dewey, Stanford Univ Medical Ctr, Stanford, CA; Evan E Eichler, Univ of Washington, Seattle, WA; Bruce D Gelb, Icahn Sch of Med at Mt. Sinai, New York, NY; Tom Quertermous, Euan A Ashley, Stanford Univ Medical Ctr, Stanford, CA; Michael A Portman, Univ of Washington, Seattle, WA, 22022/LBBS16 - Exome Sequencing of Atrioventricular Septal Defects Reveals Rare and de novo Variants in Genes Related to Congenital Heart Disease and Cardiac Development , Abstract Poster Session, LBS.02. Late-Breaking Basic Science Posters and Reception, Mon, Nov 18, 5:00 - 7:00 p.m.
Alexander C Perino, Muhammad Soofi, Stanford Univ Sch of Med, Stanford, CA; Nikhil Singh, Univ at Buffalo Sch of Med and Biomedical Sciences, Buffalo, NY; Sonya Aggarwal, Stanford Univ Sch of Med, Stanford, CA; Victor Froelicher, Palo Alto VA, Palo Alto, CA, 10703/7107 - Can the Universal Definition of Myocardial Infarction’s Electrocardiogram Criteria for Prior Myocardial Infarction be Simplified? , Abstract Poster Session, APS.717.01. Ischemic Heart Disease: Diagnosis and Prognosis, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Anne-Christine H Ruwald, Arthur J Moss, Martin H Ruwald, Univ of Rochester, Rochester, NY; Kenji Tanabe, Stanford Univ, Standford, CA; Valentina Kutyifa, Andrew Brenyo, Univ of Rochester, Rochester, NY; Christian Jons, Gentofte Univ Hosp, Hellerup, Denmark; Scott McNitt, Univ of Rochester, Rochester, NY; James P Daubert, Duke Univ Medical Ctr, Durham, NC; Amin Al-Ahmad, Paul J Wang, Stanford Univ, Stanford, CA; Wojciech Zareba, Univ of Rochester, Rochester, NY, 11330/5015 - The Influence of Percent Biventricular Pacing on CRT Efficacy Compared to ICD Therapy on Outcomes and Reverse Remodeling , Abstract Poster Session, APS.501.07. Clinical Measurements and Outcomes in Patients with Heart Failure, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
Alexander C Perino, Stanford Univ Sch of Med, Stanford, CA; Donald D Hoang, VA Palo Alto Healthcare System, Palo Alto, CA; Tyson H Holmes, Pasquale Santangeli, Stanford Univ Sch of Med, Stanford, CA; Mintu P Turakhia, VA Palo Alto Health Care System, Palo Alto, CA, 11938/4077 - Citation Bias Favoring Studies With Higher Success Rates for Catheter Ablation of Atrial Fibrillation , Abstract Poster Session, APS.406.04. Catheter Ablation of Atrial Fibrillation, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Martin H Ruwald, Arthur J Moss, Anne-Christine H Ruwald, Univ of Rochester Medical Ctr, Rochester, NY; Kenji Tanabe, Stanford Univ, Stanford, CA; Valentina Kutyifa, Univ of Rochester Medical Ctr, Rochester, NY; Christian Jons, Gentofte Hosp, Rochester, Denmark; Scott McNitt, Univ of Rochester Medical Ctr, Rochester, NY; Amin Al-Ahmad, Stanford Univ, Stanford, CA; James P Daubert, Duke Univ Medical Ctr, Durham, NC; Paul J Wang, Stanford Univ, Stanford, CA; Wojciech Zareba, Univ of Rochester Medical Ctr, Rochester, NY, 13721/4055 - The Relation Between Atrial and Ventricular Ectopic Beats, Biventricular Pacing Percentage, and Reverse Remodeling , Abstract Poster Session, APS.404.03. Resynchronization Therapy and Arrhythmias, Sun, Nov 17, 9:00 a.m. - 5:00 p.m.
Ekaterina Chernogubova, Suzanne M Eken, Karolinska Inst, Stockholm, Sweden; Joshua M Spin, Uwe Raaz, Stanford Univ, Stanford, CA; Hong Jin, Joy Roy, Anders Hamsten, Per Eriksson, Karolinska Inst, Stockholm, Sweden; Philip S Tsao, Stanford Univ, Stanford, CA; Lars Maegdefessel, Karolinska Inst, Stockholm, Sweden, 14527/7096 - MicroRNAs Are Novel Plasma Biomarkers for Diagnosis and Prognosis of Abdominal Aortic Aneurysm Disease , Abstract Poster Session, APS.728.03h. Biomarkers in Cardiac Disease and Diabetes, Wed, Nov 20, 9:00 a.m. - 12:00 p.m.
Richard D Mainwaring, V. Mohan Reddy, Frank L. Hanley, Stanford Univ Sch of Med, Stanford, CA, 9296/3048 - Three-Stage Fontan Without Cardiopulmonary Bypass , Abstract Poster Session, APS.308.02. Pediatric Cardiac Surgery: Peri- and Postoperative Issues, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
Marie-Helene Disatnik, Stanford Univ, Stanford, CA; Julio CB Ferreira, Juliane Cruz Campos, Katia Sampaio Gomes, Paulo MM Dourado, Univ of Sao Paulo, Sao Paulo, Brazil; Xin Qi, Case Western Reserve Univ Sch of Med, Cleveland, OH; Daria Mochly-Rosen, Stanford Univ, Stanford, CA, 15589/9004 - Protein-Protein Inhibitor Peptide of Drp1/Fis1 Interaction Protects the Heart Against Ischemia/Reperfusion Injury , Abstract Poster Session, APS.901.01. Best of Basic Science Abstracts and Reception, Mon, Nov 18, 5:00 - 7:00 p.m.
Carrie E Finley, David S. Leonard, Carolyn E. Barlow, The Cooper Inst, Dallas, TX; William L. Haskell, Stanford Univ, Palo Alto, CA, 18133/2100 - Between- and Within-Person Changes in Weight and Cardiorespiratory Fitness and the Effect on Blood Pressure and Lipids in Men and Women From the Cooper Center Longitudinal Study , Abstract Poster Session, APS.211.08. Environment and Comorbid Conditions in CVD, Sun, Nov 17, 9:00 a.m. - 5:00 p.m.
Anthony A Bavry, Univ of Florida, Gainesville, FL; Fridtjof Thomas, Univ of Tennessee, Memphis, TN; JoAnn E Manson, Harvard Sch of Public Health, Boston, MA; Karen C Johnson, Univ of Tennessee, Memphis, TN; Barbara V Howard, MedStar Health Res Inst, Hyattsville, MD; Matthew Allison, Univ of California San Diego Sch of Med, La Jolla, CA; Mark A Hlatky, Stanford Univ, Stanford, CA; Marian C Limacher, Univ of Florida, Gainesville, FL, 10402/2175 - Association of Non-Steroidal Anti-Inflammatory Drugs With Adverse Cardiovascular Outcomes: Results From the Women’s Health Initiative , Abstract Poster Session, APS.213.04. Medical Management: Atrial Fibrillation and Hypertension, Anticoagulants and Adherence, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
Jean-Pierre P Dery, Quebec Heart and Lung Inst, Quebec, QC, Canada; Kenneth Mahaffey, Pierluigi Tricoci, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; Harvey White, Green Lane Cardiovascular Service, Auckland, New Zealand; Mohua Podder, Canadian VIGOUR Ctr, Univ of Alberta, Edmonton, AB, Canada; David Moliterno, Gill Heart Inst and Univ of Kentucky, Lexington, KY; Robert Harrington, Stanford Univ, Stanford, CA; Edmond Chen, John Strony, Merck, Whitehouse Station, NJ; Frans Van de Werf, Leuven Catholic Univ, Leuven, Belgium; Khaled M Ziada, Gill Heart Inst, Univ of Kentucky, Lexington, KY; Claes Held, Uppsala Clinical Res Ctr, Uppsala Univ, Uppsala, Sweden; Philip Aylward, SAHMRI, Flinders Univ and Medical Ctr, Adelaide, Australia; Paul W Armstrong, Canadian VIGOUR Ctr, Univ of Alberta, Edmonton, AB, Canada; Sunil Rao, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC, 10742/6006 - Arterial Access Site and Outcomes in Patients Undergoing Percutaneous Coronary Intervention With and Without Vorapaxar , Abstract Poster Session, APS.601.02. Optimizing PCI Outcomes, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
Carolyn E Barlow, The Cooper Inst, Dallas, TX; Amy M Berkman, Univ of Vermont, Burlington, VT; William L. Haskell, Stanford Univ, Stanford, CA; Susan G. Lakoski, Univ of Vermont, Burlington, VT, 11377/2189 - Meeting the Physical Activity Guidelines and Risk of Cardiovascular Disease and Cancer Mortality: Cooper Center Longitudinal Study , Abstract Poster Session, APS.217.110. Cancer and Cardiovascular Disease II, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Cynthia Arslanian-Engoren, Univ of Michigan, Ann Arbor, MI; Jo-Ann Eastwood, UCLA, Los Angeles, CA; Marla De Jong, US Air Force Sch of Aerospace Med, Wright-Patterson AFB, OH; Kathy Berra, Stanford Univ, Palo Alto, CA, 13375/2014 - Participation in Heart Healthy Behaviors: A Secondary Analysis of the American Heart Association Go Red Heart Match Data , Abstract Poster Session, APS.205.04. Cardiovascular Disease: A Global Perspective, Wed, Nov 20, 9:00 a.m. - 12:00 p.m.
Laura Tarnawski, Lund Univ, Lund, Sweden; Iain Macaulay, Sten Erik Waelgaard Jacobsen, Oxford Univ, Oxford, United Kingdom; Sean M Wu, Stanford school of medicine, Stanford, CA; Stefan Jovinge, Lund Univ, Lund, Sweden, 13784/3004 - Single Cell Profiling Enables Surface Marker Discovery in Cardiac Progenitor Cells , Abstract Poster Session, APS.302.01. Cardiac Development and Myocardial Regeneration, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Akshay Bagai, Zhen Huang, Yuliya Lokhnygina, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; Robert A Harrington, Stanford Univ, Stanford, CA; Paul W Armstrong, Univ of Alberta, Edmonton, AB, Canada; John Strony, Edmond Chen, Merck, Whitehouse Station, NJ; Harvey D White, Green Lane Cardiovascular Service, Auckland, New Zealand; Claes Held, Uppsala Clinical Res Ctr, Uppsala Univ, Uppsala, Sweden; Frans Van de Werf, Univ Hosp Leuven, Leuven, Belgium; Lars Wallentin, Uppsala Clinical Res Ctr, Uppsala Univ, Uppsala, Sweden; Pierluigi Tricoci, Kenneth W Mahaffey, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC, 14033/2107 - Differential Prognostic Implications of Peak Troponin Level in Acute Coronary Syndrome Treated With and Without Revascularization , Abstract Poster Session, APS.212.02. Markers for Prognosis in CVD I, Sun, Nov 17, 9:00 a.m. - 5:00 p.m.
Serdar Farhan, Wilhelminenhospital, Vienna, Austria; Robert M Clare, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; Rudolf Jarai, Wilhelminenhospital, Vienna, Austria; L. Kristin Newby, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; David Morrow, TIMI Study Group, Cardiovascular Div, Brigham and Women's Hosp, Harvard Medical Sch, Boston, MA; Robert P Giugliano, TIMI Study Group, Brigham and Women’s Hosp, Boston, MA; Yuliya Lokhnygina, Duke Clinical Res Inst, Durham, NC; Robert M Califf, Duke Univ Medical Ctr, Duke Translational Med Inst, Durham, NC; Robert A Harrington, Stanford Univ, Stanford, CA; Kurt Huber, Wilhelminenhospital, Vienna, Austria, 14618/7097 - Fasting Glucose, NT-proBNP, Treatment With Glycoprotein IIb/IIIa Inhibitors, and Outcomes in Non-ST-Segment Elevation Acute Coronary Syndromes: An Analysis From EARLY ACS , Abstract Poster Session, APS.716.03. Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacological Therapy, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Muhanad Al-Zubaidi, Weston Whittington, Andrew Tseng, Banner Good Samaritan Medical Ctr, Phoenix, AZ; Paul Wang, Stanford, CA; Wilber Su, Banner Good Samaritan Medical Ctr, Phoenix, AZ, 17085/4051 - Safety and Effectiveness of Atrial Fibrillation Ablation Using the Arctic Front Advance Cryoballoon With Reduced Dosing , Abstract Poster Session, APS.406.02. Novel Technologies for AF Ablation, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Weston W Whittington, Muhanad Al-Zubaidi, Roger Tseng, Banner Good Samaritan Hosp, Phoenix, AZ; Paul Wang, Stanford Univ, Stanford, CA; Wilber Su, Banner Good Samaritan Hosp, Phoenix, AZ, 17103/4070 - Novel Utilization of Cryoballoon for Ablation of Coumadin Ridge, Left and Right Atrial Appendage for Atrial Fibrillation , Abstract Poster Session, APS.406.03. Prediction of Outcome for AF Ablation, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Marc C Engels, Rajarajan Kuppusamy, Rebecca Feistritizer, Massachusetts General Hosp, Boston, MA; Arun Sharma, Stanford Univ, Stanford, CA; Ulrik B Nielsen, Silvercreek Pharmaeceuticals, San Francisco, CA; Martin J Schalij, Antoine AF de Vries, Daniel A Pijnappels, Leiden Univ Medical Ctr, Leiden, Netherlands; Sean M Wu, Massachusetts General Hosp, Boston, MA, 17539/5074 - IGF promotes Cardiac Lineage Induction by Selective Expansion of Mesoderm in vitro , Abstract Poster Session, APS.510.02. Myocardial Response to Injury, Tue, Nov 19, 9:00 a.m. - 5:00 p.m.
Schuyler Jones, Duke Univ Medical Ctr, Durham, NC; Pierluigi Tricoci, Zhen Huang, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; David J Moliterno, Gill Heart Inst and Univ of Kentucky, Lexington, KY; Robert A Harrington, Stanford Univ, Stanford, CA; Peter Sinnaeve, Univ Hosp Leuven, Leuven, Belgium; John Strony, Merck, Whitehouse Station, NJ; Frans Van de Werf, Univ Hosp Leuven, Leuven, Belgium; Harvey D White, Green Lane Cardiovascular Service, Auckland, New Zealand; Claes Held, Uppsala Clinical Res Ctr, Uppsala Univ, Uppsala, Sweden; Paul W Armstrong, Univ of Alberta, Edmonton, AB, Canada; Philip E Aylward, SAHMRI, Flinders Univ and Medical Ctr, Adelaide, Australia; Edmond Chen, Merck, Whitehouse Station, NJ; Manesh R Patel, Kenneth W Mahaffey, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC, 17939/6023 - Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Peripheral Artery Disease: Results From TRACER , Abstract Poster Session, APS.604.02. Aortic and Peripheral Vascular Disease; Pulmonary Embolism, Mon, Nov 18, 9:00 a.m. - 5:00 p.m.
Prateeti Khazanie, Duke Medical Ctr/ DCRI, Durham, NC; Bradley G Hammill, Laura G Qualls, DCRI, Durham, NC; Gregg C Fonarow, Ahmanson-UCLA Cardiomyopathy Ctr, Los Angeles, CA; Stephen C Hammill, Mayo Clinic, Rochester, MN; Paul A Heidenreich, Palo Alto VA Medical Ctr, Palo Alto, CA; Sana M Al-Khatib, Jonathan P Piccini, Duke Medical Ctr/ DCRI, Durham, NC; Frederick A Masoudi, Pamela N Peterson, Univ of Colorado Anschutz Medical Campus, Aurora, CO; Jeptha P Curtis, Yale Univ Sch of Med, New Haven, CT; Adrian F Hernandez, Lesley H Curtis, Duke Medical Ctr/ DCRI, Durham, NC, 17532/4052 - Clinical Effectiveness of Cardiac Resynchronization Therapy Compared to Medical Therapy Alone Among Patients With Heart Failure: An Analysis of the ICD and ADHERE National Registries , Abstract Poster Session, APS.404.03. Resynchronization Therapy and Arrhythmias, Sun, Nov 17, 9:00 a.m. - 5:00 p.m.
Michael Domanski, Michael Farkouh, Icahn Sch of Med at Mount Sinai, NY, NY; Victor Zak, New England Res Insts, Watertown, MA; John Alexander, Duke Univ Medical Ctr, Durham, NC; Andrzej Bochenek, Medical Univ of Silesia, Katowice, Poland; Martial Hamon, Univ Hosp of Caen, Caen, Normandy, France; Kenneth Mahaffey, Duke Univ Medical Ctr, Durham, NC; John Puskas, Emory Hosp Midtown, Atlanta, GA; Peter Smith, Duke Univ Medical Ctr, Durham, NC; Peter Shrader, New England Res Insts, Watertown, MA; Valentin Fuster, Icahn Sch of Med at Mount Sinai, NY, NY. 15813/6076 – Perioperative CK-MB Elevation is a Better Predictor of Survival Than New Q Waves Among Diabetic Patients With Multivessel Coronary Artery Disease Undergoing CABG. Abstract Poster Session APS.608.01. Surgical Revascularization for Ischemic Heart Disease II Tue, Nov 19, 9:00 AM - 5:00 PM.
Gwen M Bernacki, Duke Clinical Res Inst, Durham, NC; Karen P Alexander, L. Kristin Newby, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; Qinghong Yang, Phillip Schulte, Duke Clinical Res Inst, Durham, NC; Harvey D White, Green Lane Cardiovascular Service, Auckland, New Zealand; E. Magnus Ohman, Kenneth W Mahaffey, Bimal R Shah, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; Robert P Giugliano, TIMI Study Group, Brigham and Women’s Hosp, Boston, MA; Paul W Armstrong, Univ of Alberta, Edmonton, AB, Canada; Robert A Harrington, Stanford Univ, Stanford, CA; Pierluigi Tricoci, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; Frans Van de Werf, Univ Hosp Leuven, Leuven, Belgium; John Alexander, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC; Robert M Califf, Duke Univ Medical Ctr, Duke Translational Med Inst, Durham, NC; Renato D Lopes, Duke Univ Medical Ctr, Duke Clinical Res Inst, Durham, NC. 9904/7129 - Trends in Enrollment, Patient Characteristics, Treatments and Outcomes of Older Adults With Non-ST-segment Elevation Acute Coronary Syndromes (ACS) in Clinical Trials. Abstract Poster Session APS.725.01. Novel Insights into the Management of ACS: Quality of Care and Outcomes Sun, Nov 17, 9:00 AM - 5:00 PM